tradingkey.logo

Microbot Medical Inc

MBOT
2.255USD
+0.175+8.41%
交易中 美东报价延迟15分钟
148.45M总市值
亏损市盈率 TTM

Microbot Medical Inc

2.255
+0.175+8.41%

关于 Microbot Medical Inc 公司

Microbot Medical Inc. is a pre-commercial stage medical technology company. It has developed the single-use, fully disposable endovascular robotic system, which aims to eliminate traditional barriers to accessing advanced robotic systems. It specializes in the research, design and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. Using its LIBERTY technological platform, it is developing a fully disposable robot for various endovascular interventional procedures. The LIBERTY Endovascular Robotic Surgical System is designed to maneuver guidewires and over-the-wire devices (such as microcatheters) within the body’s vasculature. It eliminates the need for extensive capital equipment requiring dedicated Cath-lab rooms as well as dedicated staff. Its addressable markets for the LIBERTY Endovascular Robotic Surgical System include the peripheral interventional radiology, interventional cardiology and interventional neuroradiology markets.

Microbot Medical Inc简介

公司代码MBOT
公司名称Microbot Medical Inc
上市日期Mar 25, 1992
CEOGadot (Harel)
员工数量21
证券类型Ordinary Share
年结日Mar 25
公司地址175 Derby St Bld 27
城市HINGHAM
上市交易所NASDAQ OMX - NASDAQ BASIC
国家United States of America
邮编02043
电话17818753605
网址http://www.microbotmedical.com/
公司代码MBOT
上市日期Mar 25, 1992
CEOGadot (Harel)

Microbot Medical Inc公司高管

名称
名称/职务
职务
持股
持股变动
Mr. Tal Wenderow
Mr. Tal Wenderow
Independent Director
Independent Director
--
--
Mr. David J. Wilson
Mr. David J. Wilson
Independent Director
Independent Director
--
--
Mr. Prattipati Laxminarain
Mr. Prattipati Laxminarain
Independent Director
Independent Director
--
--
Dr. Juan Diaz-Cartelle
Dr. Juan Diaz-Cartelle
Chief Medical Officer
Chief Medical Officer
--
--
Ms. Rachel Vaknin
Ms. Rachel Vaknin
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Harel Gadot
Mr. Harel Gadot
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
--
--
Mr. Scott R. Burell
Mr. Scott R. Burell
Independent Director
Independent Director
--
--
Ms. Aileen Ptucha Stockburger, CPA
Ms. Aileen Ptucha Stockburger, CPA
Independent Director
Independent Director
--
--
Mr. Simon Sharon
Mr. Simon Sharon
Chief Technology Officer, General Manager of Microbot Israel
Chief Technology Officer, General Manager of Microbot Israel
--
--
Mr. Martin J. Madden
Mr. Martin J. Madden
Independent Director
Independent Director
--
--
名称
名称/职务
职务
持股
持股变动
Mr. Tal Wenderow
Mr. Tal Wenderow
Independent Director
Independent Director
--
--
Mr. David J. Wilson
Mr. David J. Wilson
Independent Director
Independent Director
--
--
Mr. Prattipati Laxminarain
Mr. Prattipati Laxminarain
Independent Director
Independent Director
--
--
Dr. Juan Diaz-Cartelle
Dr. Juan Diaz-Cartelle
Chief Medical Officer
Chief Medical Officer
--
--
Ms. Rachel Vaknin
Ms. Rachel Vaknin
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Harel Gadot
Mr. Harel Gadot
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
--
--

收入明细

由于公司未披露,未能获取相关数据
由于公司未披露,未能获取相关数据
业务
地区
由于公司未披露,未能获取相关数据

股东统计

更新时间: 11月25日 周二
更新时间: 11月25日 周二
持股股东
股东类型
持股股东
持股股东
占比
The Vanguard Group, Inc.
3.49%
CIBC Private Wealth Management
2.17%
Susquehanna International Group, LLP
1.86%
Heights Capital Management, Inc.
1.31%
Geode Capital Management, L.L.C.
0.73%
其他
90.43%
持股股东
持股股东
占比
The Vanguard Group, Inc.
3.49%
CIBC Private Wealth Management
2.17%
Susquehanna International Group, LLP
1.86%
Heights Capital Management, Inc.
1.31%
Geode Capital Management, L.L.C.
0.73%
其他
90.43%
股东类型
持股股东
占比
Investment Advisor
8.12%
Investment Advisor/Hedge Fund
4.56%
Research Firm
0.49%
Hedge Fund
0.43%
Venture Capital
0.20%
Bank and Trust
0.04%
其他
86.16%

机构持股

更新时间: 10月1日 周三
更新时间: 10月1日 周三
报告期
机构数
持股数
持股占比
持股变动
2025Q3
108
5.08M
9.55%
-906.12K
2025Q2
93
3.71M
8.26%
-749.31K
2025Q1
89
2.58M
7.86%
-1.62M
2024Q4
78
1.58M
4.97%
-880.54K
2024Q3
70
1.52M
8.93%
-946.72K
2024Q2
71
1.56M
9.80%
-833.62K
2024Q1
69
2.54M
18.61%
-153.32K
2023Q4
67
2.61M
22.30%
+489.30K
2023Q3
65
2.09M
17.88%
-264.50K
2023Q2
64
2.33M
23.62%
-218.94K
查看更多

股东持股明细

名称
持股数
占比
持股变动
变动比例
公告日期
The Vanguard Group, Inc.
2.05M
3.86%
+1.31M
+176.68%
Jun 30, 2025
CIBC Private Wealth Management
612.00K
1.15%
+612.00K
--
Jun 30, 2025
Susquehanna International Group, LLP
31.84K
0.06%
-72.34K
-69.44%
Jun 30, 2025
Geode Capital Management, L.L.C.
395.04K
0.74%
+78.12K
+24.65%
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
313.96K
0.59%
+77.85K
+32.97%
Jun 30, 2025
DNB Asset Management AS
192.79K
0.36%
+77.97K
+67.90%
Jun 30, 2025
State Street Investment Management (US)
138.52K
0.26%
+1.85K
+1.35%
Jun 30, 2025
查看更多

持股ETF

更新时间: 12月6日 周六
更新时间: 12月6日 周六
机构名称
占比
iShares Micro-Cap ETF
0.01%
Avantis US Small Cap Equity ETF
0%
iShares Core S&P Total U.S. Stock Market ETF
0%
iShares Micro-Cap ETF
占比0.01%
Avantis US Small Cap Equity ETF
占比0%
iShares Core S&P Total U.S. Stock Market ETF
占比0%

分红派息

近5年累计派现 0.00 美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据

拆合股

公告日期
类型
比率
暂无数据
公告日期
类型
比率
暂无数据

常见问题

Microbot Medical Inc的前五大股东是谁?

Microbot Medical Inc 的前五大股东如下:
The Vanguard Group, Inc.持有股份:2.05M,占总股份比例:3.86%。
CIBC Private Wealth Management持有股份:612.00K,占总股份比例:1.15%。
Susquehanna International Group, LLP持有股份:31.84K,占总股份比例:0.06%。
Geode Capital Management, L.L.C.持有股份:395.04K,占总股份比例:0.74%。
BlackRock Institutional Trust Company, N.A.持有股份:313.96K,占总股份比例:0.59%。

Microbot Medical Inc的前三大股东类型是什么?

Microbot Medical Inc 的前三大股东类型分别是:
The Vanguard Group, Inc.
CIBC Private Wealth Management
Susquehanna International Group, LLP

有多少机构持有Microbot Medical Inc(MBOT)的股份?

截至2025Q3,共有108家机构持有Microbot Medical Inc的股份,合计持有的股份价值约为5.08M,占公司总股份的9.55%。与2025Q2相比,机构持股有所增加,增幅为1.29%。

哪个业务部门对Microbot Medical Inc的收入贡献最大?

在--,--业务部门对Microbot Medical Inc的收入贡献最大,创收--,占总收入的--%。
KeyAI